Registered entities
Arrakis Therapeutics, Inc
Reg. No. 475064524United States
Innovation
12 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,011 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 1 |
Social engagement
Social engagement: 13.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Canaan, VenBio, Nextech Invest.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 2 | 13% |
| Other / undisclosed | 5 | 33% |
Recent activity
25 Jun 2026
Leadership hire
Chief Executive Officer
26 May 2026
Event
IDMC-15 - International Myotonic Dystrophy Consortium Meeting
13 Apr 2026
Event
Drug Discovery Chemistry conference